PDCD1 and neoplasm: Strauss et al. found that targeted PD1 deficiency in myeloid-specific (Pd1 f/fLysMcre) mouse cells appeared to decrease tumor growth more than T cell specific (Pd1 f/fCD4cre) targeting [68].